O-RADS US v2022:美国放射学会卵巢-附件报告和数据系统超声委员会更新
O-RADS US 2019年首发,提供卵巢及附件病变标准化术语、基于形态特征的风险评分与管理建议。2022版更新增加提示良性形态特征(无实性成分囊肿的双房特征、光滑轮廓实性病变的声影),建议未切除的O-RADS US 3病变超声随访,强调MRI作为实性及囊实性病变的补充评估以提高特异度。
要点
- O-RADS US 3病变若未切除,推荐超声随访。
- 无实性成分囊肿的双房特征、光滑轮廓实性病变的声影为新增良性形态特征。
- 实性病变及囊实性病变强调MRI补充评估,可能提高特异度。
核心结论
- 2022版O-RADS US更新了管理概念、词典术语、评估分类及管理建议,新增提示良性形态特征并强调MRI补充评估实性及囊实性病变。
研究设计与样本
- 美国放射学会O-RADS US委员会发布的更新声明,总结2022版O-RADS US的更新内容。
关键影像表现/征象
- 新增无实性成分囊肿的双房特征及光滑轮廓实性病变的声影作为提示良性的形态特征。
诊断标准与关键数值
- O-RADS US采用基于形态特征的数值评分进行恶性风险分层。
- O-RADS US 4已被证明是恶性肿瘤的合适截断值。
- 未切除的O-RADS US 3病变推荐超声随访。
临床应用与阅片要点
- 对未切除的O-RADS US 3病变建议超声随访。
- 对实性病变及囊实性病变强调MRI作为补充评估方法,MRI可能提供更高特异度。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
First published in 2019, the Ovarian-Adnexal Reporting and Data System (O-RADS) US provides a standardized lexicon for ovarian and adnexal lesions, enables stratification of these lesions with use of a numeric score based on morphologic features to indicate the risk of malignancy, and offers management guidance. This risk stratification system has subsequently been validated in retrospective studies and has yielded good interreader concordance, even with users of different levels of expertise. As use of the system increased, it was recognized that an update was needed to address certain clinical challenges, clarify recommendations, and incorporate emerging data from validation studies. Additional morphologic features that favor benignity, such as the bilocular feature for cysts without solid components and shadowing for solid lesions with smooth contours, were added to O-RADS US for optimal risk-appropriate scoring. As O-RADS US 4 has been shown to be an appropriate cutoff for malignancy, it is now recommended that lower-risk O-RADS US 3 lesions be followed with US if not excised. For solid lesions and cystic lesions with solid components, further characterization with MRI is now emphasized as a supplemental evaluation method, as MRI may provide higher specificity. This statement summarizes the updates to the governing concepts, lexicon terminology and assessment categories, and management recommendations found in the 2022 version of O-RADS US.
引用
- Strachowski LM, Jha P, Phillips CH, et al. O-RADS US v2022: An Update from the American College of Radiology's Ovarian-Adnexal Reporting and Data System US Committee. Radiology. 2023. PMID: 37698472. doi:10.1148/radiol.230685
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。